Data as of Aug 22
| +0.66 / +0.42%|
The 16 analysts offering 12-month price forecasts for Salix Pharmaceuticals Ltd have a median target of 155.00, with a high estimate of 195.00 and a low estimate of 125.00. The median estimate represents a -2.49% decrease from the last price of 158.96.
The current consensus among 18 polled investment analysts is to Buy stock in Salix Pharmaceuticals Ltd. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.